BMJ Open, 2022 · DOI: 10.1136/bmjopen-2021-053476 · Published: January 1, 2022
This study aims to evaluate the effectiveness of rTMS in the DLPFC compared to M1 for treating neuropathic pain after SCI. Participants will be treated with rTMS for 4 weeks, and their pain, sleep, and anxiety will be assessed. The study hopes to provide more options for rTMS in treating neuropathic pain after SCI.
Provide more treatment options for neuropathic pain after SCI.
rTMS in DLPFC may affect multiple functions of pain, mood and cognition at the same time.
Clarify the efficacy of rTMS in the DLPFC in treating NPP and pain-related symptoms.